Elaine M. Hylek, MD

Professor, Medicine

Elaine Hylek
801 Massachusetts Ave Crosstown Center


Expertise includes: Arterial Thrombosis; Venous Thrombosis; Atrial Fibrillation; Safety and Effectiveness of Antithrombotic Therapy.

Other Positions

  • Active Staff Privileges, Medicine, Boston Medical Center


  • University of Pittsburgh School of Medicine, MD
  • Harvard School of Public Health, MPH
  • University of Pittsburgh, MS
  • Pennsylvania State University, BS

Classes Taught


  • Published on 7/3/2019

    Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. JAMA Cardiol. 2019 Jul 03. PMID: 31268487.

    Read at: PubMed
  • Published on 7/2/2019

    Hylek EM, Anania FA. Oral Anticoagulants in Liver Disease: Not Child's Play. J Am Coll Cardiol. 2019 Jul 02; 73(25):3309-3311. PMID: 31248552.

    Read at: PubMed
  • Published on 7/1/2019

    GuimarĂ£es PO, Lopes RD, Alexander JH, Thomas L, Hellkamp AS, Hijazi Z, Hylek EM, Gersh BJ, Garcia DA, Verheugt FWA, Hanna M, Flaker G, Vinereanu D, Granger CB. International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin. J Thromb Thrombolysis. 2019 Jul; 48(1):27-34. PMID: 30972712.

    Read at: PubMed
  • Published on 5/7/2019

    Perino AC, Shrader P, Turakhia MP, Ansell JE, Gersh BJ, Fonarow GC, Go AS, Kaiser DW, Hylek EM, Kowey PR, Singer DE, Thomas L, Steinberg BA, Peterson ED, Piccini JP, Mahaffey KW. Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry. J Am Heart Assoc. 2019 May 07; 8(9):e011205. PMID: 31023126.

    Read at: PubMed
  • Published on 4/1/2019

    Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB. Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial. J Thromb Thrombolysis. 2019 Apr; 47(3):345-352. PMID: 30790160.

    Read at: PubMed
  • Published on 2/23/2019

    Vemulapalli S, Inohara T, Kim S, Thomas L, Piccini JP, Patel MR, Chang P, Fonarow GC, Ezekowitz MD, Hylek E, Go AS, Kowey PR, Mahaffey KW, Gersh BJ, Peterson ED. Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry). Am J Cardiol. 2019 May 15; 123(10):1628-1636. PMID: 30846214.

    Read at: PubMed
  • Published on 2/8/2019

    Renda G, Patti G, Lang IM, Siller-Matula JM, Hylek EM, Ambrosio G, Haas S, De Caterina R. Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies. Int J Cardiol. 2019 07 01; 286:198-207. PMID: 30777407.

    Read at: PubMed
  • Published on 2/5/2019

    Hylek EM. Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation. Circulation. 2019 Feb 05; 139(6):772-774. PMID: 30715942.

    Read at: PubMed
  • Published on 1/30/2019

    Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019 May; 211:77-89. PMID: 30901602.

    Read at: PubMed
  • Published on 12/31/2018

    De Caterina R, Ageno W, Agnelli G, Chan NC, Diener HC, Hylek E, Raskob GE, Siegal DM, Verheugt FWA, Lip GYH, Weitz JI. The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations. Thromb Haemost. 2019 Jan; 119(1):14-38. PMID: 30597497.

    Read at: PubMed

View 241 more publications: View full profile at BUMC

View all profiles